EXEL vs HALO
Exelixis, Inc. - Common Stock · Halozyme Therapeutics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | EXEL | HALO |
|---|---|---|
| Price | $62.23 | $121.84 |
| Market Cap | $15.42B | $13.83B |
| P/E | 19.70 | 43.64 |
| P/B | 8.36 | 96.34 |
| P/S | 6.65 | 9.90 |
| ROE | 42.4% | 220.8% |
| Net Margin | 33.7% | 22.7% |
| Gross Margin | — | — |
| Revenue Growth | 7.0% | 37.6% |
| Dividend Yield | — | — |
| EPS | $3.16 | $2.79 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.